Is NSPH a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,225 people get NSPH articles and Market Currents by email alert.

Get email alerts on NSPH »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Bulls On Parade: Is Nanosphere's Bull Run Over?
EnhydrisPECorp • Tue, May 28 • 14 Comments
Nanospheres High Margin Pathogen Identification System Shows Promise
Healthcare Specialist • Wed, May 22 • 4 Comments
The Market Awaits Financial Results From Nanosphere's Gram-Positive Test
Brian L. Wilson • Thu, Jan 3 • 3 Comments
Nanosphere: Speculation Indicates Long Term Winner, Chart Technicals Indicate Possible Breakout
Scott Matusow • Wed, Aug 15, 2012 • 14 Comments
Speculative $3 Stock Gets Important FDA Approval And Has Heavy Insider Buying
Bret Jensen • Tue, Jul 24, 2012 • 13 Comments
Nanosphere: The Next Cepheid?
Jonathan Verenger • Tue, Jul 24, 2012 • 36 Comments
Nanosphere Receives Approval For Gram Positive Blood Stream Test
Steve Andrew • Wed, Jun 27, 2012 • 1 Comment
Nanosphere's Extraordinary Growth Potential in Medical Diagnostics
SeekingValue • Thu, Jun 23, 2011 • 45 Comments
Nanosphere Q1 Revenues Disappoint
Zacks Investment Research • Sun, May 10, 2009
Nanosphere Will be a Big Winner
Dan Rosenblum • Thu, Mar 20, 2008 • 9 Comments

To learn more about Seeking Alpha Pro, click here.

As The Patent Cliff Approaches, Buy TrovaGene
Logical Assessment • Wed, Jun 5 • 12 Comments
6 Ways You Can Profit From Molecular Diagnostics
Cory Renauer • Wed, May 22 • 15 Comments
A Quick Look At 8 Biotechs Ready To Gain Momentum
Craig Keolanui • Mon, Mar 11 • 10 Comments
2 $2 Biotech Stocks Insiders Are Buying
Bret Jensen • Fri, Mar 1 • 16 Comments
Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments
Insider Buying Trends: Are These Cash Rich Companies Ready To Rally?
Kapitall • Tue, Feb 5
Insider Buying Trends: Are These Cash Rich Companies Ready To Rally?
Kapitall • Fri, Jan 4
3 Low-Debt Healthcare Stocks Loaded With Cash
ZetaKap • Mon, Sep 24, 2012 • 1 Comment
The 20 Most Popular Stocks On Seeking Alpha Over The Last Month
Contextuall • Thu, Sep 13, 2012 • 10 Comments
The Top 20 Fastest Growing Stocks On Seeking Alpha
Contextuall • Tue, Aug 28, 2012 • 8 Comments
4 High-Liquid Healthcare Stocks Strongly Favored By Analysts
ZetaKap • Mon, Aug 27, 2012 • 1 Comment
Today's Select Small Cap Bio-Pharma News
Scott Matusow • Wed, Aug 15, 2012 • 10 Comments
What's Driving Stocks Tuesday: ECB And Fed Hope And Fumes
Markos Kaminis • Tue, Aug 7, 2012 • 3 Comments
3 Major Insider Buys Filed On July 23rd
Markus Aarnio • Tue, Jul 24, 2012 • 4 Comments
3 Small-Cap Pharma Plays With Minimal Debt That I'm Considering Taking A Position In
Matt Schilling • Mon, Jul 9, 2012 • 7 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Thu, Jul 5, 2012 • 11 Comments
Notable Micro Cap Insider Buys This Week
Gutone • Sun, Jun 24, 2012 • 1 Comment
Notable Micro Cap Insider Buys For The Week Of June 11-15
Gutone • Sun, Jun 17, 2012 • 4 Comments
Insiders Bought 3 Plunging Healthcare Stocks Last Week, And 3 Other Noteworthy Buys And 5 Sells
GuruFundPicks • Fri, Jun 15, 2012
Notable Micro Cap Insider Buys Last Week
Gutone • Sat, Jun 9, 2012 • 4 Comments

Nanosphere's CEO Presents at 2013 UBS Global Healthcare Services Conference (Transcript)
Thu, May 23 • 2 Comments
Nanosphere's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8
Nanosphere's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 13 • 1 Comment
Nanosphere's Management Presents at Lazard Capital Markets Healthcare Conference (Transcript)
Tue, Nov 13, 2012
Nanosphere's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Wed, Nov 7, 2012
Nanosphere's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Tue, Aug 7, 2012 • 2 Comments
Nanosphere CEO Discusses Q3 2010 Results - Earnings Call Transcript
Wed, Nov 3, 2010
Nanosphere, Inc. Q2 2010 Earnings Call Transcript
Thu, Aug 5, 2010 • 2 Comments
Nanosphere, Inc. Q1 2010 Earnings Call Transcript
Fri, May 7, 2010
Nanosphere, Inc. Q4 2008 Earnings Call Transcript
Thu, Feb 26, 2009
Nanosphere, Inc. Q3 2008 Earnings Call Transcript
Mon, Nov 10, 2008
Nanosphere, Inc. Q2 2008 Earnings Call Transcript
Thu, Aug 14, 2008
Nanosphere Incorporation Q1 2008 Earnings Call Transcript
Tue, May 13, 2008

Nanosphere to Present at the Jefferies 2013 Global Healthcare Conference

Marketwire (Jun 3, 2013)
New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013

Marketwire (May 16, 2013)
Nanosphere to Present at UBS Global Healthcare Conference

Marketwire (May 15, 2013)
Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation

Marketwire (May 13, 2013)
Nanosphere Announces Record First Quarter Revenues and Strengthens Balance Sheet With $27 Million Debt and Equity Financing

Marketwire (May 8, 2013)
Nanosphere to Release First Quarter 2013 Results and Hold Investor Conference Call on Wednesday, May 8, 2013

Marketwire (Apr 30, 2013)
Nanosphere Welcomes Ken Bahk, Ph.D. as Chief Strategy Officer and Announces Other Organizational Changes

Marketwire (Apr 25, 2013)
Nanosphere Obtains CE Mark for Gram-Negative Blood Culture Test

Marketwire (Mar 13, 2013)
Nanosphere to Present at the Cowen and Company 33rd Annual Health Care Conference

Marketwire (Feb 22, 2013)
Nanosphere Announces Record Revenues and Placements, and Key Leadership Changes

Marketwire (Feb 13, 2013)
Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13

GlobeNewswire (Feb 5, 2013)
Mark Hulbert: Small is beautiful, tiny is even better

at MarketWatch.com (Jan 2, 2013)
Nanosphere Receives FDA Clearance for C. difficile Test

GlobeNewswire (Dec 10, 2012)
Nanosphere to Present at Canaccord Genuity Medical Technology & Diagnostics Forum

GlobeNewswire (Nov 29, 2012)
Nanosphere to Present at Piper Jaffray 24th Annual Healthcare Conference

GlobeNewswire (Nov 21, 2012)
Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism

GlobeNewswire (Nov 13, 2012)
Nanosphere Announces Third Quarter 2012 Results

GlobeNewswire (Nov 7, 2012)
Nanosphere to Present at Lazard Capital Markets and Stephens Inc. Investor Conferences

GlobeNewswire (Nov 6, 2012)
Nanosphere's Bloodstream Infection Test Designated Moderate Complexity by FDA

GlobeNewswire (Nov 1, 2012)
Nanosphere to Release Q3 2012 Results and Hold Investor Call on Wednesday, November 7

GlobeNewswire (Oct 26, 2012)

NSPH vs. ETF Alternatives

Company Description

Currently, there's no company description for NSPH.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 31, 2:38 PM Nanosphere (NSPH +7.2%) pops today after Jefferies analyst Brandon Couillard assumes coverage with a Buy and raises his price target on the shares from $3.50 to $5.50. Couillard notes that NSPH's proprietary gram-positive blood stream infection test should drive significant new system placements and revenue growth over the next several years. Comment! [Healthcare, On the Move]
Tuesday, May 14, 9:10 AM Premarket gainers: PDII +33%. ECTY +20%. NSPH +18%. SNE +9%. WPX +8%. TTWO +6%. TSLA +6%. RENN +5%.
Losers: TRMD -15%. MOSY -13%. PT -11%. VELT -10%. SCTY -10%. TSL -6%. NBG -6%. 2 Comments [On the Move]
Monday, May 13, 8:53 PM Nanosphere (NSPH) expands into one of the world's largest health-care markets after signing a distribution and collaboration agreement with Hitachi High-Tech (HICTY.PK), giving the company exclusive rights to market NSPH's diagnostic test products in Japan. The two companies also plan to work together on assay and platform development. Terms of the agreement weren't disclosed. Shares +18% AH. Comment! [Healthcare, Global & FX, On the Move]
Monday, May 13, 5:45 PM After-hours top gainers, as of 5:15 p.m.: PDII +26.9%. NSPH +20.1%. III +11.6%. TTWO +4.1%. NTI +2.9%.
After-hours top losers: MOSY -9.4%. ATAX -4.6%. SPH -4.3%. WES -3.9%. IMUC -3.6%. Comment! [On the Move]
Wednesday, March 13, 10:46 AM Nanosphere (NSPH +2.2%) said it's obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its gram-negative blood-culture test on the automated sample-to-result Verigene System. The CE IVD Mark is a requirement for in vitro diagnostic medical devices marketed in Europe. Comment! [Healthcare, Global & FX, On the Move]
Friday, March 1, 1:01 PM Midday top 10 gainers: GMXR +56%. RVLT +37%. MTG +24%. ANAC +15%. DECK +14%. NSPH +13%. KERX +13%. ATEC +13%. CRIS +12%. CIDM +12%.
Midday top 10 losers: SCMR -73%. AT -29%. RNIN -23%. LTBR -23%. FWLT -17%. MDR -14%. SUP -13%. SHIP -13%. MNOV -12%. CBMX -12%. Comment! [On the Move]
Friday, March 1, 10:55 AM Nanosphere (NSPH +9.7%) gets a boost from an initiation at Canaccord with a Buy rating and a $5 price target. Canaccord says NSPH is poised to capture a big chunk of the molecular diagnostics business after revamping its strategic approach last year ago to focus on blood stream infections. The company garnered FDA approval of its Gram-Positive Blood Culture Nucleic Acid Test in June 2012, and has become an early leader in the rapid detection of sepsis, which kills around 200K Americans annually and infects over 750K. Comment! [Healthcare, On the Move]
Thursday, February 14, 3:58 PM Nanosphere (NSPH -30%) tanks today after it says that it sees FY13 sales of $13M to $15M, well under analyst expectations for $20.09M in sales this year. The company also said it is evaluating debt facilities to better manage working capital needs. Read more here: Earnings Call Transcript. 5 Comments [Healthcare, On the Move]
Thursday, February 14, 12:46 PM Midday top 10 gainers: STZ +37%. ART +32%. ANGI +24%. EMITF +21%. HNZ +20%. FFEX +20%. MEIP +18%. VCLK +17%. SPWR +17%. DSCO +16%.
Midday top 10 losers: TBAC -40%. NSPH -31%. END -31%. CTL -22%. WTW -17%. STMP -16%. STRA -11%. ULTA -11%. TCX -11%. ITRI -10%. Comment! [On the Move]
Thursday, February 14, 9:10 AM Premarket gainers: ART +33%. ANGI +30%. STZ +29%. HNZ +20%. SKX +10%. ROSG +7%. Z +8%. ANR +7%. BUD +5%. EQIX +5%.
Losers: AFFY -22%. NSPH -20%. WTW -17%. CTL -17%. TRIP -10%. ULTA -9%. WFM -7%. BBRY -5%. ARR -6%. WIN -5%. 1 Comment [On the Move]
Wednesday, February 13, 5:54 PM After-hours top gainers, as of 5:15 p.m.: ANGI +21%. BCOR +12%. JCOM +7%. VCLK +6%. SGEN +5%.
After-hours top losers: STMP -24%. NSPH -22%. WTW -16%. CTL -16%. ITRI -10%. Comment! [On the Move]
Monday, December 10, 2012, 4:03 PM Nanosphere (NSPH +2.5%) says the FDA's granted 510(k) clearance permitting marketing of its C.difficile test on the automated Verigene System. The test, which can post results in less than two hours, expands Nanosphere's infectious disease test capabilities. C. difficile infection is a cause of diarrhea that can lead to colitis, other serious intestinal conditions and death, and rapid detection can prevent further spread of the infection. Comment! [Healthcare, On the Move]
Tuesday, November 13, 2012, 12:32 PM Nanosphere (NSPH +3.5%) moves higher today after the FDA granted 510(k) clearance for the marketing of its CYP2C19 Nucleic Acid Test on the automated sample-to-result Verigene System. The test is used as an aid for clinicians to determine therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway by identifying variations directly from a patient's whole blood sample in less than 2.5 hours. Comment! [Healthcare, On the Move]
Tuesday, November 13, 2012, 9:10 AM Premarket gainers: NSPH +15%. GALE +14%. HZNP +10%. NTI +10%. GBX +8%.
Losers: HCLP -15%. AKS -12%. NBG -11%. WFT -10%. SPIL -5%. Comment! [On the Move]
Tuesday, July 31, 2012, 3:42 PM Shares of Nanosphere (NSPH +4.5%) trade higher today after being upgraded by Piper Jaffray to Overweight this morning. The firm says that there has been meaningful activity since the company's Gram Positive test was approved. The firm also raises its price target to $4 from $2. Additionally, it's worth noting that there's been some significant insider buying in the shares recently. Comment! [Healthcare, On the Move]
Thursday, July 19, 2012, 9:29 AM Nanosphere (NSPH) -3.5% premarket after the medical test developer announces its intention to offer 10.5M shares of common stock to raise proceeds for general corporate purposes and working capital. The $2.40/share price represents an 8% discount to yesterday's closing price. Comment! [Healthcare, On the Move]

Ryan Mallory
Fuinhaz Setups for April 22 2013 | $BBRY $GOLD $HLIT $NSPH $PWER $SHPG $YHOO $ZNGA | SharePlanner http://bit.ly/13qxKHm
Apr 22, 9:52 AM
Reply (28)

• !Report Abuse
View all 28 replies
DumpsterDiver: Do you believe that note about PWER was NOT embarrassingly uninformed? If so, why?
May 2, 2:28 AM
• !Report Abuse
Ryan Mallory: No I don't, and what is more embarrassing is your obsession with a comment made 10 days ago.
May 2, 8:43 AM
• !Report Abuse
Add a reply...

140 characters

ZetaKap
3 Low-Debt Healthcare Stocks Loaded With Cash http://bit.ly/QQjFw2 $BABY $HRC $NSPH @ZetaKap
9/24/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

alonfain
NSPH up today more than 9% . made a quick move on it.
9/21/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

lfpdinc
NSPH
8/28/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Contextuall
Top 100 fastest growing stocks on SeekingAlpha http://bit.ly/PKh5Kc $KCG $PSTI $NRF $LEAP $ARCT $VELT $NSPH $MLNX $QRE $VNR $APU
8/27/12
Reply (8)

• !Report Abuse
View all 8 replies
Ocean Man: Now we need to find out if SA interest correlates with good or bad stock performance.
8/28/12
• !Report Abuse
Contextuall: Working on it...hope to have something up by Thursday...
8/28/12
• !Report Abuse
Add a reply...

140 characters

ZetaKap
4 High-Liquid Healthcare Stocks Strongly Favored By Analysts http://bit.ly/MVQ9ad $DSCI $HZNP $NSPH $TRIB @ZetaKap
8/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
6 Big Volume Plays Setting Up Nicely http://bit.ly/MJX1Hw ELLI VRNG REXX SRPT NSPH WOOF
8/21/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Scott Matusow
$NSPH beginning to break out in the rubber band wedge continuation triangle. I should get my short term target very soon of over $4
8/20/12
Reply (7)

• !Report Abuse
View all 7 replies
Pescoe: Yes, we all miss you.
8/23/12
• !Report Abuse
alonfain: Scott - what's your opinion of the stock now, since it went above $3.5 and fell ?
8/24/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
My new article is out @ http://seekingalpha.com/a/hbqh $NSPH
8/15/12
Reply (1)

• !Report Abuse
View all 1 replies
LEIGHDIST: Scott, why the drop in ISR and do you see it again at 1.20
8/15/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$NSPH - let's see what happens tomorrow, got a continuation triangle - bullish. $3.75 might be coming soon there
8/14/12
Reply (3)

• !Report Abuse
View all 3 replies
DANDISIK: Con't What may happen, if there is a high opening - the next day - we may end up chasing the stock (NSPH) & end up buying at a higher price
8/14/12
• !Report Abuse
StockMatusow: no, tried that, causes too much volatility bro.
8/15/12
• !Report Abuse
Add a reply...

140 characters

LATEST REPLIES

Ryan Mallory
Fuinhaz Setups for April 22 2013 | $BBRY $GOLD $HLIT $NSPH $PWER $SHPG $YHOO $ZNGA | SharePlanner http://bit.ly/13qxKHm
Apr 22, 9:52 AM
Reply (28)

• !Report Abuse
View all 28 replies
DumpsterDiver: Do you believe that note about PWER was NOT embarrassingly uninformed? If so, why?
May 2, 2:28 AM
• !Report Abuse
Ryan Mallory: No I don't, and what is more embarrassing is your obsession with a comment made 10 days ago.
May 2, 8:43 AM
• !Report Abuse
Add a reply...

140 characters

Contextuall
Top 100 fastest growing stocks on SeekingAlpha http://bit.ly/PKh5Kc $KCG $PSTI $NRF $LEAP $ARCT $VELT $NSPH $MLNX $QRE $VNR $APU
8/27/12
Reply (8)

• !Report Abuse
View all 8 replies
Ocean Man: Now we need to find out if SA interest correlates with good or bad stock performance.
8/28/12
• !Report Abuse
Contextuall: Working on it...hope to have something up by Thursday...
8/28/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$NSPH beginning to break out in the rubber band wedge continuation triangle. I should get my short term target very soon of over $4
8/20/12
Reply (7)

• !Report Abuse
View all 7 replies
Pescoe: Yes, we all miss you.
8/23/12
• !Report Abuse
alonfain: Scott - what's your opinion of the stock now, since it went above $3.5 and fell ?
8/24/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
My new article is out @ http://seekingalpha.com/a/hbqh $NSPH
8/15/12
Reply (1)

• !Report Abuse
View all 1 replies
LEIGHDIST: Scott, why the drop in ISR and do you see it again at 1.20
8/15/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$NSPH - let's see what happens tomorrow, got a continuation triangle - bullish. $3.75 might be coming soon there
8/14/12
Reply (3)

• !Report Abuse
View all 3 replies
DANDISIK: Con't What may happen, if there is a high opening - the next day - we may end up chasing the stock (NSPH) & end up buying at a higher price
8/14/12
• !Report Abuse
StockMatusow: no, tried that, causes too much volatility bro.
8/15/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
I like the chart on $NSPH - looks like a breakout might be close there.
8/14/12
Reply (3)

• !Report Abuse
View all 3 replies
GVT: Scott - What is the pps that you expect to move on this one?
8/14/12
• !Report Abuse
StockMatusow: 3.75
8/14/12
• !Report Abuse
Add a reply...

140 characters

NSPH Nanosphere, Inc.

NSPH

Nanosphere, Inc.